How Sanofi Is Writing The Social Media Rules For Big Pharma Without Running Afoul Of The FDA
By Ben Paynter, fastcompany.com
The biggest challenge to treating patients with diabetes isn’t doling out medications, it’s making sure that people control their habits. Poor diet and lack of exercise generally create complications with the disease. To combat …
Related articles
- Sanofi’s move to acquire Regeneron shares triggers market buzz (fiercebiotech.com)
- Sanofi backs mobile service for cancer patients on chemo (fiercebiotechit.com)
- Regeneron Shares Spike as Sanofi Moves to Boost Stake (blogs.wsj.com)
- Drug Companies Doing It Right: Sanofi U.S (medmeme.com)
- European shares turn flat as Ahold, Sanofi gain (uk.reuters.com)
- Profiles of Drug Companies “Doing it Right”: Sanofi-Pasteur (medmeme.com)
- How Sanofi Is Writing The Social Media Rules For Big Pharma Without Running Afoul Of The FDA (pharmastrategic.com)
- Sanofi Shares Slump on Forecast for 5% Profit Drop This Year (bloomberg.com)
- Why Sanofi SA (NYSE:SNY) is Set for a Great 2013 (insidermonkey.com)
- How Farmers Outmarketed Pharma (georgevanantwerp.com)